Form D · Other Health Care
Ambra Bioscience LLC
San Diego, CA · CIK 0001632112
Offering snapshot reported Dec 11, 2017 · SEC filing
- Reported sold
- $1.05M Offering amount: $1.05M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2017 | Initial | $1,050,000 | No comparison | 14 | SEC filing |
| May 10, 2017 | Initial | $960,000 | No comparison | 4 | SEC filing |
| Sep 27, 2016 | Initial | $650,000 | No comparison | 6 | SEC filing |
| Feb 2, 2015 | Initial | $1,165,000 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300462
Source: Form D, filed Dec 11, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martin Brown | Director, Executive |
| Gerald Finken | Director |
| Russ Lebovitz | Director |
| William Trebasky | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11975 El Camino Real Suite 305
San Diego, CA, 92130
San Diego, CA, 92130